Posts

Posted on

Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

PR Newswire


MILWAUKEE
, Nov. 14, 2025 /PRNewswire/ — The Ademi Firm is investigating Repare (Nasdaq: RPTX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with XenoTherapeutics, Inc.

Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.

In the transaction, Repare shareholders will receive an estimated $1.82 per share in cash at closing, based on the company’s current estimates. The final payment amount will be determined by Repare’s cash balance at closing after deducting transaction costs and outstanding liabilities. Additionally, shareholders will receive one non-transferable contingent value right (CVR) per share, entitling them to portions of future proceeds from existing partnerships and potential asset dispositions. The CVRs provide varying percentages of net proceeds from partnerships with Bristol-Myers Squibb, Debiopharm and DCx Biotherapeutics, ranging from 90% to 75% depending on timing over a 10-year period.

Repare insiders will receive substantial benefits as part of change of control arrangements.

The transaction agreement unreasonably limits competing transactions for Repare by imposing a significant penalty if Repare accepts a competing bid. We are investigating the conduct of the Repare board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi & Fruchter LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-the-ademi-firm-investigates-whether-repare-therapeutics-inc-is-obtaining-a-fair-price-for-its-public-shareholders-302616105.html

SOURCE Ademi LLP

Posted on

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit

PR Newswire


NEW YORK
, Nov. 14, 2025 /PRNewswire/ — 

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the “Class Period”) of the important December 29, 2025 lead plaintiff deadline.

So what: If you purchased DexCom securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the DexCom class action, go to https://rosenlegal.com/submit-form/?case_id=28133 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 29, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) DexCom had made material design changes to the G6 and G7 continuous glucose monitoring (“CGM”) systems that were unauthorized by the U.S. Food and Drug Administration (the “FDA”); (2) the foregoing design changes rendered the G6 and G7 less reliable than their prior iterations, presenting a material health risk to users relying on those devices for accurate glucose readings; (3) accordingly, defendants’ purported enhancements to the G7, as well as the device’s reliability, accuracy, and functionality, were overstated; (4) Defendants downplayed the true scope and severity of the issues and health risks posed by adulterated G7 devices; (5) all the foregoing subjected DexCom to an increased risk of heightened regulatory scrutiny and enforcement action, as well as significant legal, reputational, and financial harm; and (6) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the DexCom class action, go to https://rosenlegal.com/submit-form/?case_id=28133 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dxcm-investors-have-opportunity-to-lead-dexcom-inc-securities-fraud-lawsuit-302616094.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

Public Service Company of New Mexico Declares Preferred Dividend

PR Newswire

ALBUQUERQUE, N.M., Nov. 14, 2025 /PRNewswire/ — The Board of Directors of Public Service Company of New Mexico, a subsidiary of TXNM Energy (NYSE: TXNM), declared the regular quarterly dividend of $1.145 per share on the 4.58 percent series of cumulative preferred stock. The preferred stock dividend is payable January 15, 2026, to shareholders of record at the close of business December 31, 2025.

Background:

TXNM Energy (NYSE: TXNM), an energy holding company based in Albuquerque, New Mexico, delivers energy to more than 800,000 homes and businesses across Texas and New Mexico through its regulated utilities, TNMP and PNM. For more information, visit the company’s website at www.TXNMEnergy.com.

CONTACTS:


Analysts


Media

Lisa Goodman

Corporate Communications

(505) 241-2160

(505) 241-2743

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/public-service-company-of-new-mexico-declares-preferred-dividend-302616160.html

SOURCE TXNM Energy, Inc.

Posted on

OceanPal Inc. Announces NASDAQ Ticker Change from “OP” to “SVRN”

PR Newswire


ATHENS, Greece and NEW YORK, Nov. 14, 2025 /PRNewswire/ — OceanPal Inc. (NASDAQ: OP) (“OceanPal” or the “Company”) today announced that it plans to change its stock ticker symbol from “OP” to “SVRN”.

Beginning Monday, November 17, 2025, shares of the Company’s common stock will trade on Nasdaq under the new ticker symbol “SVRN” and all trading activity, regulatory filings, and market-related information will be reported under the new symbol. The Company is not undertaking any other corporate action that affects the rights of outstanding common stock, and no action is required by shareholders in connection with the ticker symbol change. The Company’s common stock will continue to be listed on Nasdaq, and its CUSIP will remain unchanged.

About OceanPal Inc.

OceanPal Inc. is a global provider of shipping transportation services, specializing in the ownership and operation of dry bulk vessels and product tankers. OP is engaged in the seaborne transportation of bulk commodities, including iron ore, coal, and grain, as well as refined petroleum products. OP’s fleet is primarily employed on time charter trips with short to medium duration and spot charters, with a strategic focus on maximizing long-term shareholder value.

About SovereignAI

SovereignAI is a wholly owned subsidiary of OP formed to implement the company’s digital asset treasury strategy, and developer of confidential AI infrastructure offering a superior path to get exposure to the intersection of AI and blockchain in the public markets. SovereignAI will use NEAR Protocol’s purpose-built technology to establish private, user-owned agentic commerce. Funds generated by SovereignAI’s holistic treasury management strategy of NEAR tokens will be used to further the Company’s goal of building unique blockchain-native AI infrastructure.

To learn more about SovereignAI, please visit: https://www.svrn.net/

Media Contact: [email protected]

Cision View original content:https://www.prnewswire.com/news-releases/oceanpal-inc-announces-nasdaq-ticker-change-from-op-to-svrn-302616156.html

SOURCE OceanPal Inc.

Posted on

FCX INVESTOR ALERT: Freeport-McMoRan Inc. Investors with Substantial Losses Have Opportunity to Lead the Freeport-McMoRan Class Action Lawsuit

PR Newswire


SAN DIEGO
, Nov. 14, 2025 /PRNewswire/ —  Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Freeport-McMoRan Inc. (NYSE: FCX) publicly traded securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”), have until January 12, 2026 to seek appointment as lead plaintiff of the Freeport-McMoRan class action lawsuit.  Captioned Reed v. Freeport-McMoRan Inc., No. 25-cv-04243 (D. Ariz.), the Freeport-McMoRan class action lawsuit charges Freeport-McMoRan and certain of Freeport-McMoRan’s top current and former executives with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the Freeport-McMoRan class action lawsuit, please provide your information here:


https://www.rgrdlaw.com/cases-freeport-mcmoran-inc-class-action-lawsuit-fcx.html
 

You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].

CASE ALLEGATIONS: Freeport-McMoRan engages in the mining of mineral properties in North America, South America, and Indonesia.  Freeport-McMoRan operates the Grasberg Copper and Gold Mine in Papua, Indonesia, in which the Indonesian government holds a commercial interest, according to the complaint.

The Freeport-McMoRan class action lawsuit alleges that throughout the Class Period defendants made false and/or misleading statement and/or failed to disclose that: (i) Freeport-McMoRan did not adequately ensure safety at the Grasberg Block Cave mine in Indonesia; (ii) the lack of proper safety precautions constituted a heightened risk that could foreseeably lead to the death of Freeport-McMoRan’s workers; and (iii) this constituted an undisclosed heightened risk of regulatory, litigation, and reputational risk.

The Freeport-McMoRan class action lawsuit further alleges that on September 9, 2025, Freeport-McMoRan disclosed that “a large flow of wet material from a production drawpoint occurred at one of five production blocks in the Grasberg Block Cave underground mine,” which “blocked access to certain areas within the mine, restricting evacuation routes for seven team members.”  Freeport-McMoRan further allegedly disclosed that “[m]ining operations in the Grasberg minerals district have been temporarily suspended to prioritize the safe evacuation of the seven contractor workers.”  On this news, the price of Freeport-McMoRan stock fell nearly 6%, according to the complaint.

Then, on September 24, 2025, the complaint further alleges that Freeport-McMoRan revealed that “two team members . . . were regrettably fatally injured in the September 8th incident,” “[e]xtensive efforts are ongoing in the search for five [PT  Freeport Indonesia (“PTFI”)] team members who remain missing,” and “mining operations in the Grasberg minerals district have been temporarily suspended since September 8th.”  Freeport-McMoRan allegedly further disclosed that “PTFI production in 2026 could potentially be approximately 35% lower than pre-incident estimates.”  On this news, the price of Freeport-McMoRan stock fell nearly 17%, according to the complaint.

Finally, on September 25, 2025, the Freeport-McMoRan class action lawsuit alleges that Bloomberg published an article entitled “Freeport Mine Setback Risks Fraying Relations With Indonesia,” which stated, in pertinent part, that “[a] halt in production at the giant Grasberg copper mine in Indonesia looks set to strain the fractious relationship between Freeport-McMoRan Inc. and its host nation, at a time when the Jakarta government was already looking to take greater control.”  The complaint alleges that on this news, the price of Freeport-McMoRan stock fell more than 6%.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Freeport-McMoRan publicly traded securities during the Class Period to seek appointment as lead plaintiff in the Freeport-McMoRan class action lawsuit.  A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.  A lead plaintiff acts on behalf of all other class members in directing the Freeport-McMoRan investor class action lawsuit.  The lead plaintiff can select a law firm of its choice to litigate the Freeport-McMoRan shareholder class action lawsuit.  An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Freeport-McMoRan class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder litigation.  Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors.  In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS.  With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig.  Please visit the following page for more information:


https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices. 

Contact:
               Robbins Geller Rudman & Dowd LLP
               J.C. Sanchez, Jennifer N. Caringal
               655 W. Broadway, Suite 1900, San Diego, CA 92101
               800-449-4900
              [email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/fcx-investor-alert-freeport-mcmoran-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-freeport-mcmoran-class-action-lawsuit-302616127.html

SOURCE Robbins Geller Rudman & Dowd LLP

Posted on

LRN LAWSUIT ALERT: Levi & Korsinsky Notifies Stride, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Stride investors who were adversely affected by alleged securities fraud between October 22, 2024 and October 28, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/stride-inc-lawsuit-submission-form-3?prid=177507&wire=3

LRN investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: According to the filed complaint, defendants made false statements and/or concealed that Stride was (1) inflating enrollment numbers by retaining “ghost students”; (2) cutting staffing costs by assigning teachers’ caseloads far beyond the required statutory limits; (3) ignoring compliance requirements, including background checks and licensure laws for its employees, and ignoring federally mandated special education services to students; (4) suppressing whistleblowers who documented financial directives from Stride’s leadership to delay hiring and deny services to preserve profit margins; and (5) losing existing and potential enrollments.

WHAT’S NEXT? If you suffered a loss in Stride during the relevant time frame, you have until January 12, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



Posted on

Genius Group files Federal Securities Class Action Lawsuit against Citadel Securities and Virtu Financial for Alleged Market Manipulation.

SINGAPORE, Nov. 14, 2025 (GLOBE NEWSWIRE) —
Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced it has filed a Class Action Complaint in the United States District Court for the Southern District of New York alleging that Citadel Securities LLC, and Virtu Americas LLC (the “Defendants”) engaged in a long-running market manipulation scheme that includes spoofing and naked short selling of the Company’s shares and related acts in violation of Section 10(b), Sections 9(a)(2) and 9(e) and Section 20(a) of the Securities Exchange Act of 1934.

The Company believes the lawsuit sets a number of precedents with regards to the protection of shareholder interests and the Company. As such, the Company is taking action to recover damages caused due to alleged market manipulation:


  • This lawsuit is a


    Class Action Complaint


    filed on behalf of the Company and ALL of its investors who sold Genius Group stock at artificially deflated prices as a result of Defendants’ alleged abuses.

  • Pursuing a class action will help the Company facilitate a recovery not just for Genius Group’s losses, but for all its harmed shareholders as well.

  • The Company will ask the Court to appoint it “lead plaintiff” in the class action, so that the Company can effectively manage the litigation and diligently work to protect its shareholders’ interests.

The class action complaint filed today that Defendants engaged in longstanding and widespread manipulative trading scheme centered on repeatedly “spoofing” Genius Group stock. “Spoofing” is a manipulative and illegal trading practice that involves submitting and then cancelling buy or sell orders without any genuine intent to execute them. The purpose of these “baiting orders” is to mislead other market participants about the level of supply and/or demand for a security, or about the degree of price volatility associated with a security, and thereby influence market prices for that security.

The complaint alleges that for a period of at least three years – between April 12, 2022 and May 30, 2025 (the “Class Period”) – Defendants repeatedly entered thousands of spoofing trades designed to create the false impression that there was both excess supply and excess volatility in Genius stock. The Company has confirmed that the lawsuit seeks at least the previously reported no less than $250 million in damages.

These manipulative orders were calculated to (and successfully did) deceive or induce other investors to sell their holdings at artificially deflated prices. In particular, the complaint alleges:

  • On 98%of all trading days during the Class Period, Defendants repeatedly entered spoofing trades designed to manipulate the price of Genius stock. Defendants entered dozens – sometimes thousands – of such trades on a given trading day, canceling them within milliseconds of placement.
  • Defendants repeatedly built massive short positions through off-exchange trading over a few trading days, and then bombarded the market with spoofing trades (baiting orders canceled within100 milliseconds of placement) causing significant declines in the price of Genius Group stock.

  • Less than a minute
     after these baiting orders were placed, Defendants sold significant volumes of Genius stock short through off-exchange trading.
  • Defendants also engaged in significant naked short-selling, i.e., improper short sales that are unsupported by existing market inventory. Indeed, major declines in Genius Group stock were also accompanied by large spikes in evidence of such activity.

In filing this class action, Genius Group is demonstrating its commitment to its shareholders and the Company intends to work diligently to protect their interests.

Roger James Hamilton, CEO of Genius Group, said “We have been consistent in calling for fair markets and taking actions to protect our shareholders. The filing of this lawsuit is an important milestone for the company in what has been a long, multi-year fight to protect the company and its shareholders and expose unfair and illegal practices that our investors have dealt with.”

“Even today, multiple brokers have taken away the buy button on Genius shares while leaving the sell button, making it hard to buy but easy to sell our stock without providing adequate explanation as to why they are choosing to target our company. We give notice to any and all bad actors seeking to profit at the expense of our shareholders that we will continue to take forceful, proactive action to defend our company.”

The Company and its legal team will continue to provide updates to its shareholders on this case as appropriate. The Company also reminds shareholders of the record date of November 28, 2025 to transfer shares via the Direct Registration System (DRS) to book entry with the Company’s transfer agent, VStock in order to benefit from the Bitcoin Loyalty Payment program, designed to reduce the number of Company shares available to short sellers. Full details of the program can be found here.

About Genius Group

Genius Group (NYSE: GNS) is a Bitcoin-first business delivering AI powered, education and acceleration solutions for the future of work. Genius Group serves 6 million users in over 100 countries through its Genius City model and online digital marketplace of AI training, AI tools and AI talent. It provides personalized, entrepreneurial AI pathways combining human talent with AI skills and AI solutions at the individual, enterprise and government level. To learn more, please visit https://www.geniusgroup.ai/

Forward-Looking Statements 

Statements made in this press release include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by the use of words such as “may,” “will”, “plan,” “should,” “expect,” “anticipate,” “estimate,” “continue,” or comparable terminology. Such forward-looking statements are inherently subject to certain risks, trends and uncertainties, many of which the Company cannot predict with accuracy and some of which the Company might not even anticipate and involve factors that may cause actual results to differ materially from those projected or suggested. Readers are cautioned not to place undue reliance on these forward-looking statements and are advised to consider the factors listed above together with the additional factors under the heading “Risk Factors” in the Company’s Annual Reports on Form 20-F, as may be supplemented or amended by the Company’s Reports of a Foreign Private Issuer on Form 6-K. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise. No information in this press release should be construed as any indication whatsoever of the Company’s future revenues, results of operations, or stock price.

Contacts

For enquiries, contact [email protected]



Posted on

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cidara Therapeutics, Inc. (NASDAQ: CDTX)

NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Cidara Therapeutics, Inc. (NASDAQ: CDTX) related to its sale to Merck Sharp & Dohme LLC. Under the terms of the proposed transaction, Cidara shareholders will receive $221.50 per share in cash. Is it a fair deal?

Click here for more info 

https://monteverdelaw.com/case/cidara-therapeutics-inc/

.
It is free and there is no cost or obligation to you.

NOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a lawyer and ask:

  1. Do you file class actions and go to Court?
  2. When was the last time you recovered money for shareholders?
  3. What cases did you recover money in and how much?

About Monteverde & Associates PC

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

No one is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.



Posted on

Dynamix Corporation III Announces the Separate Trading of its Class A ordinary shares and Warrants Commencing November 19, 2025

Houston, TX, Nov. 14, 2025 (GLOBE NEWSWIRE) — Dynamix Corporation III (the “Company”) today announced that commencing November 19, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade the Class A ordinary shares and warrants included in the units. Class A ordinary shares and warrants that are separated will trade on the Nasdaq Stock Market LLC under the ticker symbol “DNMX” and “DNMXW,” respectively. Those units not separated will continue to trade on the Nasdaq Stock Market LLC under the symbol “DNMXU.” No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Odyssey Transfer and Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering of units was made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained from: Cohen & Company Capital Markets, 3 Columbus Circle, 24th Floor, New York, NY 10019, Attention: Prospectus Department, Email: [email protected].

About Dynamix Corporation III

Dynamix Corporation III is a special purpose acquisition company incorporated under the laws of the Cayman Islands for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an initial business combination in any business or industry, but expects to target opportunities and companies that are in the energy, power and digital infrastructure value chain. The Company is led by the following seasoned investors and industry executives: Andrea “Andrejka” Bernatova, Chief Executive Officer and Chairman, Nader Daylami, Chief Financial Officer, Philip Rajan, Executive Vice President of M&A and Strategy. The Company maintains a corporate website at https://dynamix3.dynamix-corp.com/. Inclusion of the Company’s website address in this press release is an inactive textual reference only.

Contacts

Dynamix Corporation III
Andrea Bernatova
1980 Post Oak Blvd., Suite 100,
PMB 6373,
Houston, TX 77056

Tel: (646) 792 5600



Posted on

Viking Acquisition Corp. I Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing November 20, 2025

NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) — Viking Acquisition Corp. I (NYSE: VACI.U) (“Company”) announced today that holders of the Company’s public units may elect to separately trade the Class A ordinary shares and warrants underlying such public units commencing on November 20, 2025. Each unit consists of one Class A ordinary share and one third of one redeemable warrant of the Company. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. 

Those public units not separated will continue to trade under the symbol “VACI.U.” The Class A ordinary shares and warrants that are separated will trade on the New York Stock Exchange under the ticker symbols “VACI” and “VACI WS,” respectively. Holders of public units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the public units into Class A ordinary shares and warrants.

A final prospectus relating to and describing the final terms of the offering has been filed with the SEC. The offering was made only by means of a prospectus, copies of which may be obtained by contacting Cohen & Company Capital Markets, a Division of Cohen & Company Securities, LLC, 3 Columbus Circle, 24th Floor, New York, NY 10019, Attention: Prospectus Department, or by email at: [email protected]. Copies of the final prospectus can also be accessed through the SEC’s website at www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Viking Acquisition Corp. I

Viking Acquisition Corp. I is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the separation of the public units into Class A ordinary shares and warrants. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and final prospectus for the Company’s offering filed with the SEC, which could cause actual results to differ from the forward-looking statements. Copies are available on the SEC’s website, www.sec.gov. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law.



Contact

Gil Ottensoser
Chief Financial Officer
[email protected]
(917) 423-7931